NLRP3 and acute pancreatitis: Furthermore, polydatin has been identified as a promising therapeutic agent that, by targeting different states of the NLRP3 inflammasome complex, shows potential in treating acute pancreatitis (AP) and other NLRP3-related inflammatory diseases.